S
RYTM icon

SignatureFD’s Rhythm Pharmaceuticals RYTM Stock Holding History

SignatureFD’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Buy
231
+7
+3% +$633 ﹤0.01% 2223
2026
Q1 		$19.5K Sell
224
-8
-3% -$778 ﹤0.01% 2210
2025
Q4 		$24.8K Hold
232
– – ﹤0.01% 2020
2025
Q3 		$23.4K Buy
232
+8
+4% +$743 ﹤0.01% 2038
2025
Q2 		$14.2K Hold
224
– – ﹤0.01% 2202
2025
Q1 		$11.9K Buy
224
+2
+0.9% +$111 ﹤0.01% 2287
2024
Q4 		$12.4K Buy
222
+9
+4% +$497 ﹤0.01% 2291
2024
Q3 		$11.2K Hold
213
– – ﹤0.01% 2294
2024
Q2 		$8.75K Hold
213
– – ﹤0.01% 2326
2024
Q1 		$9.23K Hold
213
– – ﹤0.01% 2326
2023
Q4 		$9.79K Buy
213
+9
+4% +$284 ﹤0.01% 2268
2023
Q3 		$4.68K Sell
204
-23
-10% -$515 ﹤0.01% 2517
2023
Q2 		$3.74K Buy
227
+23
+11% +$415 ﹤0.01% 2612
2023
Q1 		$3.64K Hold
204
– – ﹤0.01% 2624
2022
Q4 		$5.94K Hold
204
– – ﹤0.01% 2388
2022
Q3 		$5K Buy
+204
New +$3.79K ﹤0.01% 2461
2022
Q2 		– Sell
-69
Closed -$1K – 3313
2022
Q1 		$1K Sell
69
-42
-38% -$369 ﹤0.01% 3051
2021
Q4 		$1K Sell
111
-1,853
-94% -$20.8K ﹤0.01% 2983
2021
Q3 		$26K Buy
1,964
+1,464
+293% +$22.4K ﹤0.01% 1639
2021
Q2 		$10K Sell
500
-168
-25% -$3.49K ﹤0.01% 1998
2021
Q1 		$14K Buy
+668
New +$19.4K ﹤0.01% 1717
2020
Q4 		– Sell
-200
Closed -$4K – 2682
2020
Q3 		$4K Buy
+200
New +$4.58K ﹤0.01% 1991

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SignatureFD's RYTM Position: Q2 2026 in Review

SignatureFD increased its Rhythm Pharmaceuticals (RYTM) stake by 3.1% in Q2 2026, buying an estimated $633 and bringing the position to 231 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

SignatureFD first reported a position in RYTM in Q3 2020 and has held it in 22 quarters since. The position peaked at $26K in Q3 2021. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • SignatureFD held 231 shares of Rhythm Pharmaceuticals worth $25.6K as of Q2 2026.
  • SignatureFD bought 7 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $633.
  • Rhythm Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2223 holding.
  • SignatureFD first reported a position in Rhythm Pharmaceuticals in Q3 2020 and has held it in 22 quarters since.
  • SignatureFD's Rhythm Pharmaceuticals position peaked at $26K in Q3 2021.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.